RECRUITING

Gestational Diabetes Mellitus (GDM) in Pregnant Women

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the trial is to discover and predict the development of GDM of pregnant women in their first trimester.

Official Title

A Single Site, Observational, Administered to Pregnant Women at High Risk for Gestational Diabetes Mellitus

Quick Facts

Study Start:2021-11-09
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05265741

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Nini Fan, MS,MBA
CONTACT
6469458999
nini.fan@mamome.io

Principal Investigator

Joseph Morin, PhD
STUDY_CHAIR
Long Island University
Jeanmaire Molina, PhD
PRINCIPAL_INVESTIGATOR
Long Island University
Xuebin Yin, MD
PRINCIPAL_INVESTIGATOR
BROOKLYN INNOSEQ INC.

Study Locations (Sites)

Long Island University
New York, New York, 11201
United States

Collaborators and Investigators

Sponsor: Long Island University

  • Joseph Morin, PhD, STUDY_CHAIR, Long Island University
  • Jeanmaire Molina, PhD, PRINCIPAL_INVESTIGATOR, Long Island University
  • Xuebin Yin, MD, PRINCIPAL_INVESTIGATOR, BROOKLYN INNOSEQ INC.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-09
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2021-11-09
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • Gestational Diabetes Mellitus

Additional Relevant MeSH Terms

  • Gestational Diabetes Mellitus
  • Pregnancy Complications